Takeda and Shire had combined sales of almost US$30 billion in 2017, which would comfortably put the new entity in the top ten pharmaceutical companies by revenue. …
Latest Video
Georgia Forrest
New Stories
-
New digital health reforms to give Australians a more complete medicines history
January 28, 2026 - - Latest News -
Peer-reviewed validation strengthens Paradigm’s osteoarthritis program
January 28, 2026 - - Australian Biotech -
Obesity medicines, the limits of the PBS, and the test of policy imagination
January 28, 2026 - - Latest News -
Patrys completes Reliis acquisition, expands clinical pipeline and strengthens board
January 28, 2026 - - Australian Biotech -
Trump administration launches third round of price negotiations, including the first renegotiation
January 28, 2026 - - Latest News -
UK life sciences report highlights pressures familiar to Australian industry
January 27, 2026 - - Latest News -
Americans pay a much lower share of health costs than we do in Australia
January 27, 2026 - - Latest News